JNJ Stock: Spinoff, Sales Growth Will Create Value
24 Dezember 2021 - 05:43PM
TipRanks
With a market cap of $442 billion and annual revenues exceeding $94
billion, Johnson & Johnson (JNJ) is one of the world's largest
and most diverse healthcare companies. The company operates under
three divisions: Pharmaceutical, Medical Devices, and Consumer.
However, in November of this year, JNJ announced plans to spin off
the consumer division. The Pharmaceutical and Medical Devices
segments represent about 80% of sales and drive the majority of
cash flows for the firm. The pharmaceutical portfolio focuses on
immunology, oncology, neurology, pulmonary, cardiology, and
metabolic diseases. The medical device segment focuses on
orthopedics, surgery tools, and vision care.
https://www.tipranks.com/news/article/jnj-stock-spinoff-sales-growth-will-create-value?utm_source=advfn.com&utm_medium=referral
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
Von Apr 2022 bis Mai 2022
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
Von Mai 2021 bis Mai 2022